Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial.
Steffi HartmannT KühnJana de BonifaceA StachsA WinckelmannJ FrisellI Wiklander-BråkenhielmJ StubertB GerberT ReimerPublished in: The British journal of surgery (2021)
Targeted axillary dissection after carbon tattooing is associated with a high detection rate, an acceptable false-negative rate, and appears feasible for clinical use even in healthcare settings with limited resources.
Keyphrases
- lymph node
- healthcare
- study protocol
- cancer therapy
- neoadjuvant chemotherapy
- sentinel lymph node
- clinical trial
- ultrasound guided
- randomized controlled trial
- phase ii
- cross sectional
- double blind
- squamous cell carcinoma
- real time pcr
- young adults
- radiation therapy
- cell therapy
- mesenchymal stem cells
- health information